China Universal Asset Management Co., Ltd. Mersana Therapeutics, Inc. Transaction History

China Universal Asset Management Co., Ltd.

$893 Million
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 21, 2024	BUY	$1.06 - $3.91 $1,691 - $6,240	1,596 Added 106.47%	3,095 $3,000
Q3 2023 Oct 30, 2023	BUY	$1.06 - $3.91 $1,691 - $6,240	1,596 Added 106.47%	3,095 $4,000
Q2 2023 May 21, 2024	BUY	$3.08 - $9.55 $110 - $343	36 Added 2.46%	1,499 $4,000
Q2 2023 Jul 27, 2023	BUY	$3.08 - $9.55 $110 - $343	36 Added 2.46%	1,499 $5,000
Q1 2023 May 21, 2024	BUY	$4.0 - $7.02 $1,796 - $3,151	449 Added 44.28%	1,463 $6,000
Q1 2023 Apr 27, 2023	BUY	$4.0 - $7.02 $1,796 - $3,151	449 Added 44.28%	1,463 $6,000
Q4 2022 May 21, 2024	BUY	$5.65 - $7.86 $5,729 - $7,970	1,014 New	1,014 $5,000
Q4 2022 Jan 31, 2023	BUY	$5.65 - $7.86 $587 - $817	104 Added 11.43%	1,014 $6,000
Q3 2022 Oct 21, 2022	BUY	$4.63 - $8.0 $4,213 - $7,280	910 New	910 $6,000

Others Institutions Holding MRSN

# of Institutions

121

Shares Held

116M

Call Options Held

233K

Put Options Held

457K

Eco R1 Capital, LLC San Francisco, CA

19.4M
Shares

$39.5 Million
1.59% of portfolio
Nextech Invest Ag

12.1M
Shares

$24.6 Million
3.72% of portfolio
Vr Adviser, LLC New York, NY

11.3M
Shares

$23.1 Million
2.22% of portfolio
Bain Capital Life Sciences Investors, LLC Boston, MA

8.66M
Shares

$17.7 Million
2.94% of portfolio
Black Rock Inc. New York, NY

8.38M
Shares

$17.1 Million
0.0% of portfolio

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $198M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account